ReviewInternational journal of women's health2026
Phase-Based Management of Heavy Menstrual Bleeding in Women with Bleeding Disorders: From Acute Control to Long-Term Maintenance.
Review in International journal of women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Heavy menstrual bleeding (HMB) is a common and clinically challenging manifestation in women with inherited or acquired bleeding disorders (BDs), often leading to iron-deficiency anemia, recurrent emergency visits, transfusion requirements, and impaired quality of life. Although current management strategies commonly distinguish acute from long-term treatment, this binary approach may not adequately address the vulnerable interval after initial bleeding control, during which recurrent bleeding remains common and definitive maintenance therapy may not yet be feasible. In this narrative review, we propose a phase-based framework for the management of HMB in women with BDs, organized into acute bleeding control, bridging stabilization, and long-term maintenance. Acute management should be guided by hemodynamic status and may include resuscitation, correction of anemia and hemostatic defects, high-dose combined hormonal therapy or high-dose progestins, antifibrinolytic therapy, and selected mechanical interventions. Bridging stabilization aims to maintain endometrial quiescence, prevent early recurrence, allow hematologic recovery, and create a safer window for transition to definitive long-term therapy. Potential bridging options include progestin-based regimens, continuous combined hormonal regimens in appropriate patients, depot progestins, antifibrinolytic therapy during bleeding episodes, and selected use of low-dose mifepristone. Long-term maintenance should be individualized according to the underlying bleeding disorder, thrombotic risk, anticoagulant use, fertility goals, treatment acceptability, and patient preference. The levonorgestrel-releasing intrauterine system should be regarded primarily as a definitive long-term maintenance option rather than a conventional bridging therapy, and its insertion may be delayed until bleeding is controlled and hematologic conditions permit safe placement. This phase-based approach may provide a practical framework for multidisciplinary care, but prospective studies are needed to compare bridging strategies, define optimal transition pathways, and evaluate standardized outcomes in this high-risk population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.